Health Canada Approves Illuccix® for Prostate Cancer Imaging
Go back to Health Canada Approves Illuccix® for Prostate Cancer Imaging| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 9.51 +0.25 (2.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.26 | 52 Week High | $2.18 | |||
| Open | $9.55 | 52 Week Low | $0.30 | |||
| Day High | $9.60 | P/E | N/A | |||
| Day Low | $9.48 | EPS | $-3.32 | |||
| Volume | 211,313 | |||||



